bimagrumab glp-1 Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during receptor agonism Trial suggests GLP-1 combo therapy
Pay in 4 interest-free payments of $5.76 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14




























